Wellumio Secures $9.8 Million in Latest Pre-Series A Funding Round

Wellumio secured $9.8 million in its latest Pre-Series A, adding another data point to the Healthcare & Life Sciences funding market.

Wellumio Raises $9.8 million in Funding

Wellumio closed an oversubscribed $9.75M Pre-Series A to accelerate portable stroke imaging technology.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Wellumio operates in Healthcare & Life Sciences. Portable point-of-care neuro-imaging drawing early capital to cut stroke diagnosis time. Title-only extraction (Tavily 432); LOW confidence.

Strategic Use of Funds

Accelerate portable stroke imaging technology

Looking Ahead

Wellumio Closes Oversubscribed $9.75 Million Pre-Series A Round

Source reference: original announcement/article.